Difficulty: Medium
Average Score: 67%
Practice
Which of the following has no muscarinic blocking activity:
Correct answer
D
Rationale
In this question, the correct answer is D) Edrophonium, as it has no muscarinic blocking activity. Edrophonium is a short-acting cholinesterase inhibitor used for the diagnosis of myasthenia gravis, as it temporarily increases the levels of acetylcholine at the neuromuscular junction.
Now let's analyze why the other options are incorrect:
A) Amitriptyline: Amitriptyline is a tricyclic antidepressant with significant anticholinergic effects, including muscarinic receptor blocking activity.
B) Meperidine: Meperidine is an opioid analgesic that does not have direct muscarinic blocking activity, but it can cause anticholinergic side effects such as dry mouth and constipation.
C) Ipratropium: Ipratropium is an anticholinergic bronchodilator used in conditions like COPD and asthma. It specifically blocks muscarinic receptors in the airways to cause bronchodilation.
Educational context: Understanding the pharmacological actions of drugs affecting the central and peripheral nervous system is crucial for healthcare professionals. Knowledge of muscarinic blocking activity is essential in the context of managing various conditions like asthma, COPD, and myasthenia gravis. Identifying drugs with specific pharmacological properties helps in selecting appropriate treatment regimens and managing potential side effects effectively.
Now let's analyze why the other options are incorrect:
A) Amitriptyline: Amitriptyline is a tricyclic antidepressant with significant anticholinergic effects, including muscarinic receptor blocking activity.
B) Meperidine: Meperidine is an opioid analgesic that does not have direct muscarinic blocking activity, but it can cause anticholinergic side effects such as dry mouth and constipation.
C) Ipratropium: Ipratropium is an anticholinergic bronchodilator used in conditions like COPD and asthma. It specifically blocks muscarinic receptors in the airways to cause bronchodilation.
Educational context: Understanding the pharmacological actions of drugs affecting the central and peripheral nervous system is crucial for healthcare professionals. Knowledge of muscarinic blocking activity is essential in the context of managing various conditions like asthma, COPD, and myasthenia gravis. Identifying drugs with specific pharmacological properties helps in selecting appropriate treatment regimens and managing potential side effects effectively.